FDA Vascular

Pulmonary arterial hypertension device wins FDA breakthrough designation

Released on September 9, 2019

Dive Brief: Tel Aviv-based SoniVie has received FDA’s breakthrough device designation for its treatment for pulmonary arterial hypertension (PAH), a form […]

Read more
Neuro Radiology Vascular

Sensor Monitors Brain Aneurysms Post Treatment

Released on August 30, 2019

Aneurysms within the brain are extremely dangerous, although there are therapies available such as stents and blood flow diverters. Even after […]

Read more
Funding Vascular

NIH Awards Sonavex, Inc. $3 Million Grant to Pursue New Vascular Surgery Applications for EchoMark® & EchoSure®

Released on August 30, 2019

Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced that it received a $3 million Phase […]

Read more
Funding Vascular

Cerus Endovascular tops $5m funding goal, raises target to $20m

Released on August 29, 2019

Cerus Endovascular raised its fundraising goal to $20 million this week after it pushed past its previous $5 million target by about $900,000…

Read more
MedTech Vascular

Pulmonx touts new coverage for Zephyr valve

Released on August 29, 2019

Pulmonx said today that its Zephyr valve designed to treat chronic respiratory disease is now covered by Priority Health under a revised lung volume…

Read more
Neuro Vascular

Cerus Endovascular starts European trial of intracranial aneurysm device

Released on August 29, 2019

Cerus Endovascular said it has enrolled the first patients in a study designed to assess the safety of the company’s Contour neurovascular system, which is designed to reduce the risk of…

Read more
Public Offering Vascular

Avinger prices $5m offering

Released on August 22, 2019

Avinger (NSDQ:AVGR) yesterday priced a stock offering worth nearly $5 million for its line of devices to treat…

Read more
M&A Vascular

Boston Scientific Closes Acquisition of BTG plc.

Released on August 19, 2019

Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc. (LSE: BTG) pursuant to the previously announced…

Read more
FDA Vascular

Endologix Takes a Step Forward with Nellix IDE

Released on August 12, 2019

Endologix has received investigational device exemption (IDE) approval from FDA for a new pivotal study to evaluate the safety and effectiveness of the…

Read more
CE Mark Vascular

New Device Supports Dialysis Fistulas

Released on August 7, 2019

Vascular Graft Solutions, a company based in Tel Aviv, Israel, has won the European CE Mark for its…

Read more
CE Mark Vascular

Vascular Graft Solutions wins CE Mark for fistula repair device

Released on August 6, 2019

Vascular Graft Solutions today announced that it received CE Mark approval for its Frame FR external support…

Read more
M&A Vascular

Hillrom to pay $130m for Breathe Technologies as fiscal Q3 numbers top forecast

Released on August 5, 2019

Hillrom (NYSE:HRC) said today that it agreed to pay $130 million in cash for Breathe Technologies and posted fiscal third-quarter numbers that topped the …

Read more